Altre lingue Consolidated Gems, Inc.

Azioni

Tempo differito OTC Markets Altri mercati azionari			Variaz. 5gg	Var. 1 gen.
- ^USD	-.--%		-.--%	-.--%

01/05	CONSOLIDATED GEMS, INC. : giudizio positivo da Stifel Nicolaus	ZM
29/04	Cullinan Therapeutics nomina Mary Kay Fenton come direttore finanziario	MT

Cullinan Therapeutics Appoints Mary Kay Fenton as CFO	29/04
Cullinan Oncology Finance Chief Jeffrey Trigilio to Leave	14/03
Cullinan Oncology Secures FDA Approval for CLN-619's Investigational New Drug Application in Multiple Myeloma	01/03
Cullinan Oncology Insider Sold Shares Worth $647,200, According to a Recent SEC Filing	05/02
Cullinan Oncology Insider Sold Shares Worth $563,600, According to a Recent SEC Filing	31/01
Cullinan Oncology Doses First Patient in Study of Advanced Solid Tumor Treatment Candidate	15/12
Insider Sell: Cullinan Oncology	08/06/23
Cullinan Oncology Gets FDA Clearance for CLN-617 Study	27/03/23
Cullinan Oncology's Q4 Loss Narrows	09/03/23
Cullinan Oncology to Pay $25 Million for License Agreement With Harbour BioMed	14/02/23
Cullinan Oncology Says US FDA Approves Investigational New Drug Application for CLN-978	24/01/23
Cullinan Oncology Posts Wider Q3 Loss; Cash, Equivalents Decline	14/11/22
Cullinan Oncology Raises Stake in Cullinan MICA Unit to 92%	25/10/22
Cullinan Oncology Swings to Profit in Q2	10/08/22
Insider Sell: Cullinan Oncology	26/07/22
Insider Sell: Cullinan Oncology	21/07/22
Cullinan Oncology Finalizes Collaboration Deal With Taiho Pharmaceutical	23/06/22
Insider Buy: Cullinan Oncology	07/06/22
Cullinan Oncology Q1 Net Loss Narrows	16/05/22
Earnings Flash (CGEM) CULLINAN ONCOLOGY Posts Q1 Loss $-0.27	16/05/22

Non ci sono risultati per questa ricerca